RecruitingAnkylosing SpondylitisAutoimmune DiseaseCrohn Disease
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study learn how easily patients can use an educational tool that will be created for patients with melanoma and pre-existing autoimmune diseases who receive or will receive immune checkpoint inhibitor drugs. Patients will be asked their opinions about the design, accessibility, and content of the tool. Researchers will use the information collected to improve the educational materials that will help patients make future decisions about their treatment.
Sponsor: M.D. Anderson Cancer Center
You may qualify if…
- ✓ Diagnosis of melanoma
- ✓ Diagnosis of pre-existing autoimmune disease
- ✓ Inflammatory bowel disease
- ✓ Diagnosis of Crohn's disease or ulcerative colitis by a gastroenterologist
- ✓ For ulcerative colitis, proof of chronic changes over time (i.e., 6 months) and signs of inflammation histologically
- ✓ Treatment with aminosalicylates, corticosteroids, thiopurines, or immune modifiers (e.g., calcineurin inhibitors, methotrexate, adhesion molecule antagonists)
- ✓ Rheumatoid arthritis
- ✓ Diagnosis of rheumatoid arthritis by a rheumatologist
Where it's recruiting
Texas
Houston
Source: ClinicalTrials.gov · NCT04751396 · last updated 2026-05-20